A detailed history of Klp Kapitalforvaltning As transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 21,100 shares of COLL stock, worth $970,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,100
Previous 19,600 7.65%
Holding current value
$970,177
Previous $579,000 27.46%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$29.75 - $39.59 $44,625 - $59,385
1,500 Added 7.65%
21,100 $738,000
Q2 2025

Jul 23, 2025

SELL
$24.67 - $30.44 $261,502 - $322,664
-10,600 Reduced 35.1%
19,600 $579,000
Q1 2025

May 06, 2025

BUY
$28.04 - $33.91 $126,180 - $152,594
4,500 Added 17.51%
30,200 $901,000
Q4 2024

Feb 11, 2025

BUY
$28.61 - $41.86 $735,277 - $1.08 Million
25,700 New
25,700 $736,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.57B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.